← Open Payments lookup

MOTAZ ALHOMSI: Open Payments

NPI 1154455798 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,424 in 57 payments from 11 companies in 2025. Trend: 2023 $632 · 2024 $812 · 2025 $1,424

Food & beverage: $1,424
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc8$253
Teva Pharmaceuticals USA, Inc.10$245
Otsuka America Pharmaceutical, Inc.9$237
Vanda Pharmaceuticals Inc.10$207
Neurocrine BioSciences, Inc.8$188
Alkermes, Inc.3$94
E.R. Squibb & Sons, L.L.C.3$71
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$51
ABBVIE INC.2$31
Supernus Pharmaceuticals, Inc.1$28

Products named: INVEGA SUSTENNA, FANAPT, UZEDY, INGREZZA, ABILIFY ASIMTUFII, ARISTADA, REXULTI, COBENFY.

Industry payments across PA — which companies pay providers there.